Epidemiol Mikrobiol Imunol. 2022 Spring;71(1):40-47.
Between 2017 and 2019, measles virus spread globally, causing a large measles epidemic that suddenly ended in 2020. Measles outbreaks also occurred in the Czech Republic (CR) as part of the global public health problem. In the recent alarming epidemiological situation, molecular surveillance is becoming increasingly important as it plays a vital role in the identification of imported cases and in the monitoring of virus transmission. Molecular surveillance makes it possible to obtain evidence of the discontinuation of the endemic spread and is indispensable for the verification of measles elimination. The study aim is to find out whether any of measles virus genotypes circulated in the CR for more than 12 months in order to either confirm or refute the endemic spread of measles virus in the country in relation to the recent loss of the measles elimination status. Another aim is to assess the current laboratory diagnosis from the perspective of recent measles outbreaks and the obligation to refer samples for confirmation and genotyping.
In total, 243 positive nasopharyngeal swabs collected from outbreak patients from all over the CR in 2018 and 2019 were analysed by molecular methods. The most variable part of the measles virus genome, the nucleoprotein gene (N-450), was sequenced according to the WHO protocol. The sequence analysis was performed by Sanger method using the Applied Biosystems 3 500 sequencer, and sequence data were analysed by the bioinformatics programe Geneious.
In the CR, only two genotypes were found in measles outbreaks in 2018-2019, eight variants of the dominant D8 and six B3 variants, while genotype A was detected in eight samples. The dominant genotype of 2017 (D8, 4283) was identified for the first time in the CR in January 2018. Four months later, it was replaced by genotype D8, 4683, occurring in the CR from March 2018 to June 2019. This genotype was identified in 170 of 243 samples (70%). There was a 3-month window between the first and the second detection of this genotype, which does not imply that in the meantime the virus did not circulate in the population. The analysis of seven samples from 2017 conducted by the collaborating Regional Reference Laboratory at the Robert Koch Institute (RRL RKI) in Berlin assigned five samples from Ostrava to genotype B3 and detected two variants of genotype D8 (Praha, Liberec). Laboratory diagnosis was facilitated by a higher proportion of clinical specimens available for direct detection of the virus, which increased from 18% in 2017 to 43% in 2019. Samples were referred to the National Reference Laboratory (NRL) in Prague for sequencing in accordance with the set legal rules. Between 2018 - 2019, laboratories sent 424 samples. Two hundred and forty-three samples (60%) were successfully sequenced, while the sequencing of the remaining samples failed due to low viral load.
Measles virus sequencing was introduced in the Czech Republic as a necessary part of molecular surveillance, and almost 60% of positive samples were analysed. The sequencing analysis confirmed the endemic spread of measles virus, with genotype D8, 4683 MVs/GirSomnath.IND/42.16 found to circulate in the CR for 16 months between 2018 and 2019. Laboratory diagnosis is recently focusing more on direct detection of the virus, which along with genotyping extended to include another part of the genome will improve molecular surveillance.
2017 年至 2019 年期间,麻疹病毒在全球范围内传播,导致麻疹疫情突然在 2020 年结束。捷克共和国(CR)也发生了麻疹疫情,这是全球公共卫生问题的一部分。在最近令人震惊的流行病学形势下,分子监测变得越来越重要,因为它在识别输入病例和监测病毒传播方面发挥着至关重要的作用。分子监测使我们能够获得停止地方性传播的证据,并且对于验证消除麻疹至关重要。本研究旨在确定在 CR 中是否有麻疹病毒基因型传播超过 12 个月,以便确认或反驳该国麻疹病毒地方性传播的情况,以及最近失去消除麻疹地位的情况。另一个目的是评估从最近的麻疹暴发和将样本送检进行确认和基因分型的义务的角度来看,当前的实验室诊断。
共分析了 2018 年和 2019 年来自 CR 各地暴发患者的 243 份鼻咽拭子,采用分子方法。根据世界卫生组织(WHO)的协议,对麻疹病毒基因组中最具变异性的部分,即核蛋白基因(N-450)进行测序。序列分析采用 Sanger 法,使用 Applied Biosystems 3 500 测序仪进行,序列数据通过生物信息学程序 Geneious 进行分析。
在 2018-2019 年的麻疹暴发中,CR 只发现了两种基因型,分别是 8 种主要 D8 变体和 6 种 B3 变体,而基因型 A 则在 8 个样本中检测到。2017 年的主要基因型(D8,4283)于 2018 年 1 月首次在 CR 中被发现。四个月后,它被发生在 2018 年 3 月至 2019 年 6 月期间的基因型 D8,4683 取代。在 243 份样本中,有 170 份(70%)检测到这种基因型。在首次和第二次检测这种基因型之间有一个 3 个月的窗口期,这并不意味着在此期间病毒没有在人群中传播。合作的罗伯特科赫研究所(RRL RKI)区域参考实验室对 2017 年的 7 个样本进行的分析将来自奥斯特拉瓦的 5 个样本分配给基因型 B3,并检测到基因型 D8 的两个变体(布拉格,利贝雷茨)。实验室诊断得到了更大部分的临床标本的直接检测的促进,直接检测的比例从 2017 年的 18%增加到 2019 年的 43%。实验室按照规定的法律规则将样本送往国家参考实验室(NRL)进行测序。2018 年至 2019 年期间,实验室共发送了 424 份样本。243 份(60%)样本成功测序,而其余样本由于病毒载量低而测序失败。
麻疹病毒测序作为分子监测的必要组成部分在捷克共和国引入,近 60%的阳性样本得到了分析。测序分析证实了麻疹病毒的地方性传播,发现 2018 年至 2019 年间在 CR 传播的基因型 D8,4683 MVs/GirSomnath.IND/42.16 持续了 16 个月。最近,实验室诊断更加注重病毒的直接检测,这与基因分型一起扩展到包括基因组的另一部分,将改善分子监测。